Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily.
第一作者:
Gretchen M,Schroeder
第一单位:
Bristol-Myers Squibb Research and Development, Princeton, New Jersey, 08543-4000, USA. gretchen.schroeder@bms.com
作者:
医学主题词
投药, 口服(Administration, Oral);氨基吡啶类(Aminopyridines);动物(Animals);抗肿瘤药(Antineoplastic Agents);细胞系, 肿瘤(Cell Line, Tumor);结晶学, X线(Crystallography, X-Ray);二氢吡啶类(Dihydropyridines);狗(Dogs);人类(Humans);小鼠(Mice);小鼠, 裸(Mice, Nude);模型, 分子(Models, Molecular);原癌基因蛋白质c-met(Proto-Oncogene Proteins c-met);吡啶酮类(Pyridones);大鼠(Rats);溶解度(Solubility);构效关系(Structure-Activity Relationship);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1021/jm801586s
PMID
19260711
发布时间
2022-03-31
- 浏览22
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



